The primary actions of GLP-1 include stimulating insulin secretion from pancreatic beta cells in response to elevated blood glucose (importantly, this insulin release is glucose-dependent, reducing hypoglycaemia risk), suppressing glucagon release (which prevents the liver from producing excess glucose), and slowing gastric emptying
After eligibility determination, 358 articles were excluded, leaving 26 articles to be used for analysis
Inquire about warning signs that require urgent medical attention, such as severe abdominal pain, gallbladder symptoms (right upper quadrant pain, fever, yellowing of skin), allergic reactions, or signs of dehydration
Body weight analysis highlighted an important distinction
It reflects average blood glucose levels over the preceding 2 to 3 months
Asian Australasian Journal of Animal Science, 19(10): 1478-1483, ISSN: 1011-2367